Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet
Authors:
- Giuseppe DerosaGDGiuseppe Derosa
- Amedeo MugelliniAMAmedeo Mugellini
- Leonardina CiccarelliLCLeonardina Ciccarelli
- Roberto FogariRFRoberto Fogari
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (4) , 1107-1122
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Burden of Illness Review of Obesity: Are the true costs realised?Journal of the Royal Society of Health, 1998
- Obesity, Health Services Use, and Health Care Costs Among Members of a Health Maintenance OrganizationArchives of internal medicine (1960), 1998
- OrlistatDrugs, 1998
- Science, medicine, and the future: Obesity treatmentBMJ, 1997
- Range of serum cholesterol values in the population developing coronary artery diseaseThe American Journal of Cardiology, 1995
- Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in WomenAnnals of Internal Medicine, 1995
- Pathophysiology of obesityThe American Journal of Clinical Nutrition, 1992
- Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.BMJ, 1991
- Diabetes Intervention Study: Multi-Intervention Trial in Newly Diagnosed NIDDMDiabetes Care, 1991
- Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.Circulation, 1983